Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 9/20 | 0.57 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.51 |
| ▸ | CASP1 | P29466 | 1/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.47 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14345560 | 1.00 | OPRD1 (0.57) | OPRD1GRIA1CASP1OPRM1OPRK1 | |
| SCHEMBL14274753 | 0.89 | OPRM1 (0.56) | OPRD1OPRM1 | |
| SCHEMBL21880937 | 0.89 | GRIA1 (0.59) | OPRD1GRIA1OPRM1OPRK1 | |
| SCHEMBL30493746 | 0.89 | GRIA1 (0.61) | OPRD1GRIA1OPRM1OPRK1 | |
| SCHEMBL14366618 | 0.89 | GRIA1 (0.55) | OPRD1GRIA1 | |
| SCHEMBL14279285 | 0.89 | GRIA1 (0.55) | OPRD1GRIA1 | |
| SCHEMBL30493755 | 0.87 | ACE (0.56) | OPRD1GRIA1CASP1 | |
| SCHEMBL14345567 | 0.85 | GRIA1 (0.53) | OPRD1GRIA1OPRM1OPRK1 | |
| SCHEMBL14345510 | 0.82 | GRIA1 (0.52) | OPRD1GRIA1CASP1OPRM1OPRK1 | |
| SCHEMBL24310822 | 0.80 | CASP1 (0.63) | OPRD1GRIA1CASP1OPRM1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8034898-B2 | Methods of collagen imaging | Collagen Medical, LLC (US) | 2011-10-11 | — | — | US | disclosed |
| US-8034898-B2 | Methods of collagen imaging | Collagen Medical, LLC (US) | 2011-10-11 | — | — | US | disclosed |
| US-20080058636-A1 | METHODS OF MYOCARDIAL IMAGING | EPIX PHARMACEUTICALS, INC. | 2008-03-06 | — | — | US | disclosed |
| US-20080058636-A1 | METHODS OF MYOCARDIAL IMAGING | EPIX PHARMACEUTICALS, INC. | 2008-03-06 | — | — | US | disclosed |
| US-20080044360-A1 | METHODS OF COLLAGEN IMAGING | EPIX PHARMACEUTICALS, INC. | 2008-02-21 | — | — | US | disclosed |
| US-20070293656-A1 | COLLAGEN BINDING PEPTIDES | EPIX PHARMACEUTICALS, INC. | 2007-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080058636-A1 | METHODS OF MYOCARDIAL IMAGING | FABP3, TNNI3, TNNT2 | OPRD1 4369/4885GRIA1 4457/4885CASP1 3369/4885 |
| US-20080044360-A1 | METHODS OF COLLAGEN IMAGING | COL14A1, COL2A1, COL1A1 | OPRD1 4516/4885GRIA1 3889/4885CASP1 1749/4885 |
| US-20070293656-A1 | COLLAGEN BINDING PEPTIDES | COL14A1, COL2A1, COL1A1 | OPRD1 4183/4885GRIA1 3653/4885CASP1 1905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.